Mast cells and chemokines

Journal of Biological Regulators and Homeostatic Agents

Volumn 22, Issue 3, 2008, Pages 145-151

  Katsanos, G S ^a   Anogeianaki, A ^a   Orso, C ^a   Tete S ^a   Salini, V ^a   Antinolfi, P L ^b   Sabatino, G ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

Allergic diseases; Chemokines; Cytokines; Mast cells

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR;

CLASSIFICATION; EDITORIAL; GENETICS; HUMAN; MAST CELL; METABOLISM;

CHEMOKINES; HUMANS; MAST CELLS; RECEPTORS, CHEMOKINE;

EID: 58949086593     PISSN: 0393974X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Palmqvist C, Wardlaw AJ, Bradding P. Chemokines and their receptors as potential targets for the treatment of asthma. Br J Pharmacol 2007; 151: 725-736. (Pubitemid 47075313)
2. Castellani ML, Bhattacharya K, Tagen M, et al. Anti-chemokine therapy for inflammatory diseases. Int J Immunopathol Pharmacol 2007; 20(3):447-53. (Pubitemid 47534148)
3. Bodini A, D'Orazio C, Peroni DG, et al. IL-8 and pH values in exhaled condensate after antibiotics in cystic fibrosis children. Int J Immunopathol Pharmacol 2007; 20(3):467-72. (Pubitemid 47531050)
4. Hauswirth AW, Sonneck K, Florian S, et al. Interleukin-3 promotes the expression of E-NPP3/ CD203C on human blood basophils in healthy subjects and in patients with birch pollen allergy. Int J Immunopathol Pharmacol 2007; 20(2):267-78. (Pubitemid 47104847)
5. Di Sciascio MB, Vianale G, Verna N, et al. Eosinophil recruiting chemokines are down-regulated in peripheral blood mononuclear cells of allergic patients treated with deflazacort or desloratadine. Int J Immunopathol Pharmacol 2007; 20(4):745-51.
6. Feliciani C, Ruocco E, Zampetti A, Toto P, Amerio P, Tulli A, Amerio P, Ruocco V. Tannic acid induces in vitro acantholysis of keratinocytes via IL-1 alpha and TNF-alpha. Int J Immunopathol Pharmacol 2007; 20(2):289-99. (Pubitemid 47104849)
7. Anogianaki A, Negrev NN, Shaik YB, et al. Capsaicin: an irritant anti-inflammatory compound. J Biol Regul Homeost Agents 2007; 21:1-4. (Pubitemid 351513877)
8. Mayerhofer M, Aichberger KJ, Florian S, Valent P. Recognition sites for microbes and components of the immune system on human mast cells: relationship to CD antigens and implications for host defense. Int J Immunopathol Pharmacol 2007; 20(3):421-34. (Pubitemid 47534147)
9. Bodo M, Muzi G, Bellucci C, et al. Comparative in vitro studies on the fibrogenic effects of two samples of silica on epithelial bronchial cells. J Biol Regul Homeost Agents 2007; 21:97-104. (Pubitemid 351524043)
10. Rubegni P, Sbano P, Cevenini G, et al. CD4+CD25+ lymphocyte subsets in chronic graft versus host disease patients undergoing extracorporeal photochemotherapy. Int J Immunopathol Pharmacol 2007; 20(4):801-7.
11. Theoharides TC, Makris M, Kalogeromitros D. Allergic inflammation and adipocytokines. Int J Immunopathol Pharmacol 2008; 21(1):1-4. (Pubitemid 351500995)
12. Foschino Barbara MP, Carpagnano GE, Spanevello A, Cagnazzo MG, Barnes PJ. Inflammation, oxidative stress and systemic effects in mild chronic obstructive pulmonary disease. Int J Immunopathol Pharmacol 2007; 20(4):753-63.
13. Parri N, Bernardini R, Pucci N, Novembre E, Azzari C, Vierucci A. Drug rash with eosinophilia and systemic symptoms induced by lamotrigine therapy. Int J Immunopathol Pharmacol 2007; 20(3):643-5. (Pubitemid 47531068)
14. Ronchetti R, Jesenak M, Barberi S, Ronchetti F, Rennerova Z, Trubacova D, Villa MP. Reproducibility of atopy patch tests with food and inhalant allergens. J Biol Regul Homeost Agents 2008; 22:27-33. (Pubitemid 351577890)
15. Sonneck K, Baumgartner C, Rebuzzi L, et al. Recombinant allergens promote expression of aminopeptidase-n (CD13) on basophils in allergic patients. Int J Immunopathol Pharmacol 2008; 21(1): 11-21. (Pubitemid 351500997)
16. Inoue K, Takano H, Ohnuki M, et al. Size effects of nanomaterials on lung inflammation and coagulatory disturbance. Int J Immunopathol Pharmacol 2008; 21(1):197-206. (Pubitemid 351501016)
17. Deepak P, Kumar S, Acharya A. IL-13 neutralization modulates function of type II polarized macrophages in vivo in a murine T-cell lymphoma. Eur J Inflamm 2007; 5:37-45. (Pubitemid 46779253)
18. Gelardi M, Maselli del Giudice A, Fiorella ML, et al. Quality of life in non-allergic rhinitis depends on the predominant inflammatory cell type. J Biol Regul Homeost Agents 2008; 22:73-81. (Pubitemid 351577895)
19. Befus AD, Mowat C, Gilchrist M, Hu J, Solomon S, Bateman A. Neutrophil defensins induce histamine secretion from mast cells: mechanisms of action. J Immunol 1999; 163:947-953. (Pubitemid 29328106)
20. Chertov O, Yang D, Howard OM, Oppenheim JJ. Leukocyte granule proteins mobilize innate host defenses and adaptive immune responses. Immunol Rev 2000; 177:68-78.
21. Patriarca G, Schiavino D, Lombardo C, Altomonte G, De Cinti M, Buonomo A, Nucera E. Tolerability of Aztreonam in patients with IgE-mediated hypersensitivity to beta-lactams. Int J Immunopathol Pharmacol 2008; 21:375-379. (Pubitemid 351988400)
22. D'Orlando O, Gri G, Cattaruzzi G, Merluzzi S, Betto E, Gattei V, Pucillo C. Outside inside signalling in CD40-mediated B cell activation. J Biol Regul Homeost Agents 2007; 21:49-62. (Pubitemid 351524039)
23. Campbell EM, Charo IF, Kunkel SL, Strieter RM, Boring L, Gosling J, Lukacs NW. Monocyte chemoattractant protein-1 mediates cockroach allergen-induced bronchial hyperreactivity in normal but not CCR2-/- mice: the role of mast cells. J Immunol 1999; 163:2160-2167. (Pubitemid 29382223)
24. Ciprandi G, Cirillo I, Troisi RM, Marseglia GL. Allergic subjects have more numerous respiratory infections and severe gastrointestinal infections than non-allergic subjects: preliminary results. Eur J Inflamm 2007; 5:27-29.
25. Lavagno L, Ferrero E, Ortolan E, Malavasi F, Funaro A. CD157 is part of a supramolecular complex with CD11b/CD18 on the human neutrophil cell surface. J Biol Regul Homeost Agents 2007; 21:5-12.
26. Blease K, Lukacs NW, Hogaboam CM, Kunkel SL. Chemokines and their role in airway hyper-reactivity. Respir Res 2000; 1(1):54-61. (Pubitemid 34189258)
27. Luster AD. Antichemokine immunotherapy for allergic diseases. Curr Opin Allergy Clin Immunol 2001; 1(6):561-7.
28. Theoharides TC. Mast cells and pancreatic cancer. N Engl J Med 2008; 358(17):1860-1. (Pubitemid 351581204)
29. Utsugi M, Ishizuka T, Hisada T, Sato K, Ishizuka T, Dobashi K, Mori M. Hypoxemia with high alveolar-arterial oxygen gradient but no lung involvement in a patient with Churg-Strauss syndrome: case report. Int J Immunopathol Pharmacol 2008; 21(1):251-3. (Pubitemid 351501025)
30. Bhattacharya K, Farwell K, Huang M, et al. Mast cell deficient W/Wv mice have lower serum IL-6 and less cardiac tissue necrosis than their normal littermates following myocardial ischemia-reperfusion. Int J Immunopathol Pharmacol 2007; 20(1):69-74. (Pubitemid 46506877)
31. Kaliner MA, Metcalfe DD. The mast cells in health and disease. Ed Claude Lenfant 1993; 62:1-880.
32. Toda M, Sakaguchi Y, Morimoto K. Correlation between serum IgE and salivary Cortisol levels in subjects with type I allergic disorders. Int J Immunopathol Pharmacol 2007; 20:203-5. (Pubitemid 46506894)
33. Arimoto T, Takano H, Inoue K, Yanagisawa R, Yoshino S, Yamaki K, Yoshikawa T. Pulmonary exposure to diesel exhaust particle components enhances circulatory chemokines during lung inflammation. Int J Immunopathol Pharmacol 2007; 20(1):197-201. (Pubitemid 46506893)
34. Banche G, Allizond V, Mandras N, et al. Improvement of clinical response in allergic rhinitis patients treated with an oral immunostimulating bacterial lysate: in vivo immunological effects. Int J Immunopathol Pharmacol 2007; 20(1):129-38. (Pubitemid 46506884)
35. Ingber A, Cohen Y, Krimsky M, Yedgar S. A novel treatment of contact dermatitis by topical application of phospholipase A2 inhibitor: a double-blind placebo-controlled pilot study. Int J Immunopathol Pharmacol 2007; 20(1):191-5. (Pubitemid 46506892)
36. Leitner JM, Mayr FB, Firbas C, Spiel AO, Steinlechner B, Novellini R, Jilma B. Reparixin, a specific interleukin-8 inhibitor, has no effects on inflammation during endotoxemia. Int J Immunopathol Pharmacol 2007; 20(1):25-36. (Pubitemid 46506873)
37. Cadoni S, Ruffelli M, Fusari S, de Pità O. Oral allergic syndrome and recombinant allergens rBet v 1 and rBet v 2. Eur J Inflamm 2007; 5:21-25. (Pubitemid 46779250)
38. Colanardi MC, Nettis E, Traetta P, Delle Donne P, Ferrannini A, Vacca A. Parecoxib as an alternative in COX-2 hypersensitivity. Int J Immunopathol Pharmacol 2008; 21(1):233-5. (Pubitemid 351501021)